BMEA · Biomea Fusion, Inc.
$1.73
+0.05 (+2.98%)
At close · Aug 28
Going-concern doubt
— flagged Aug 5, 2026
Substantial doubt about the company's ability to continue as a going concern.
“There is substantial doubt about our ability to continue as a going concern, and we will require substantial additional capital to finance our operations. If we are unable to raise such capital when needed, or on acceptable terms, we may be forced to delay, reduce and/or eliminate one or more of our research and product development programs or future commercialization efforts.”View the 10-Q filed Aug 5, 2026
Market Cap
$125.40M
Shares
72.48M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2023-05-19 | A2A Pharmaceuticals, Inc. | 10% Stockholder | 1,500,000 | 2023-05-19 | Jefferies LLC |
| 2023-04-27 | A2A Pharmaceuticals, Inc. | Stakeholder | 400,000 | 2023-04-27 | UBS Financial Services Inc |
| 2023-04-20 | A2A Pharmaceuticals, Inc. | 10% Stockholder | 200,000 | 2023-04-20 | Jefferies LLC |
Showing 1–3 of 3 filings
Key facts
CIK
1840439
CUSIP
09077A106
13F (30d)
52 filings
52 filers
Visit website
Investor relations